medigraphic.com
ISSN 1729-519X (Print)

2015, Number 4

<< Back Next >>

Revista Habanera de Ciencias Médicas 2015; 14 (4)

Waist-hip ratio and prostatic adenoma weight

Chávez GMA, Luna-Abanto JC

Language: Spanish
References: 34
Page: 470-477
PDF size: 65.32 Kb.


ABSTRACT

Introduction: Benign prostatic hyperplasia (BPH) and obesity are prevalent health problems in older men.
Objective: the aim of this study is to determine the existence of correlation between waist-hip ratio and the prostatic adenoma weight.
Material and Methods: 34 patients were enrolled, measurements of waist and hip circumference were performed before surgery according to the World Health Organization (WHO) protocol and the enucleated prostatic adenoma was weighed in the operating room.
Results: the average age of participants was 70 years, the average waist-hip ratio was 0.99, and the average weight of the enucleated adenoma was 54.38 g. Among the variables waist-hip ratio and weight of adenoma inverse correlation was found (r: -0.179), however this correlation is weak (r2: 0.03) and not significant (p: 0.312).
Conclusion: no correlation between waist-hip ratio and the weight of prostatic adenoma was found.


REFERENCES

  1. Cózar-Olmoa JM, Hernández-Fenández C, Minana-López B, Amón-Sesmero JH. Consensus on the clinical impact of the new scientific evidence available on benign prostatic hiperplasia. Actas Urol Esp. 2012;36(5):265-275.

  2. Duncan ME and Goldacre MJ. Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979–2006. BJU International. 2011;107:40-45.

  3. Nishant DP and Kellogg Parsons J. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014 Apr-Jun;30(2):170-176.

  4. Benign Prostatic Hyperplasia: American Urological Association revised 2010 [Internet]. [Citado 18 de julio de 2013]. Disponible en: http://goo.gl/UUkni

  5. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474.

  6. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17(3):241.

  7. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54(9):935.

  8. Messele Getahun G, Getachew Kebede A. Comparison of prostatic volume measured with abdominal ultrasound and prostatic weight determined after open enucleation performed in Gondar University Hospital, Ethiopia. African Journal of Urology. September 2008;14(2): 86-89.

  9. Kent Hoo NG, Akmal Ayob M, Mohamad Salim MI, Abduljabbar H, Supriyanto E. Prostate Volume Measurement Using Transabdominal Ultrasound Scanning. Advances in Environment, Biotechnology and Biomedicine. 2012.

  10. Yang HJ, Whan Doo, Yang WJ and Seob Song Y. Which Obesity Index Best Correlates With Prostate Volume, Prostate-specific Antigen, and Lower Urinary Tract Symptoms? Urology. 2012;80(1):187-190.

  11. Soygür T, Küpeli B, Aydos K, et al. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol. 1996;28:55-59.

  12. Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562-2568.

  13. Lee S, Min HG, Choi SH, et al. Central obesity as a risk factor for prostatic hyperplasia. Obes Silver Spring. 2006; 14:172-179.

  14. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol. 1994;140:989-1002.

  15. Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML, et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer and Prostatic Diseases. 2007;10:137-142.

  16. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991;40:101-104.

  17. Majed A, Nasser M, Al-Daghri OS, Khalid M. Alkharfy, Shaun BS and Ullrich A. Visceral obesity and inammation markers in relation to serum prostate volume biomarkers among apparently healthy men. European Journal of Clinical Investigation. 2011;41:987-994.

  18. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-1761.

  19. Yee CH, So WY, Yip SKh, Wu E, Yau P, Ng CF. Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: A randomized controlled trial. Korean J Urol. 2015 Mar;56(3):240-247.

  20. Parsons JK, Messer K, White M, Barrett-Connor E, Bauer DC, Marshall LM. Osteoporotic Fractures in Men (MrOS) Research Group and the Urologic Diseases in America Project. Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol. 2011 Dec;60(6):1173-80.

  21. Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562-2568.

  22. Burke JP, Rhodes T, Jacobson DJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol. 2006;164:41.

  23. Fritschi L, Tabrizi J, Leavy J. et al. Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health. 2007;121:781.

  24. Hsu-Han W, Chi-Jeng H, Kuo-Jen L, Sheng-Hsien Ch, Cheng-Keng Ch, Hsiao- Wen Ch, et al. Waist circumference is an independent risk factor for prostatic hyperplasia in Taiwanese males. Asian Journal of Surgery. 2011;34(4):163-167.

  25. Aguilar-Barradas J, García-Irigoyen C, Manzanilla-García HA, Castro-Ibarra M, Martínez-Hernández MC, Acevedo-García C. Estudio correlacional entre el índice de masa corporal, perímetro abdominal y volumen de la glándula prostática en pacientes con sintomatología obstructiva urinaria por crecimiento prostático. Revista Mexicana de Urología. 2010;70(3):141-145.

  26. World Health Organization. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Reporte. Geneva: December 2008;8-11.

  27. Auda Hassan A, Jabbiri A, Mohanad MH, Usama S, Nasiri A. Correlations between Preoperative Measurement of Prostate Volume by Transabdominal and Transrectal Ultrasound with Open Prostatectomy. The Iraqi Postgraduate Medical Journal. 2012;11(4):569-574.

  28. Relación entre variables cuantitativas [Internet]. [Citado 30 de enero de 2015]. Disponible en: http://goo.gl/sbceQ

  29. Pautas éticas Internacionales para la Investigación y Experimentación Biomédica en Seres Humanos de la Organización Mundial de la Salud Ginebra 2002. [Citado 30 de enero de 2015]. Disponible en: http://goo.gl/7daVC

  30. Centro Nacional de Alimentación y Nutrición, Instituto Nacional de Salud. Sala Situacional Alimentaria Nutricional 5: Sobrepeso y Obesidad. 2013.

  31. Tewari R, Rajender S, Natu SM, Dalela D, Goel A, Goel MM, et al. Diet, obesity, and prostate health: are we missing the link? J Androl. 2012 Sep-Oct;33(5):763-76.

  32. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007 Aug;178(2):395-401.

  33. Hammarsten J, Högstedt B, Holthuis N, Mellström D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 1998;1:157-62.

  34. De Nunzio C, Aronson W, Stephen J, Giovannucci E, Kellogg Parsons J. The Correlation Between Metabolic Syndrome and Prostatic Diseases. Eur Urol. 2012 Mar;61(3):560-70.




2020     |     www.medigraphic.com